DeviceTalks Podcast Network

In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses.

In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office.

Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth.

Thank you to our season one sponsors, AcuityMD and Millstone Medical for supporting this podcast. To learn more about our episode sponsor, AcuityMD, please visit http://acuitymd.com.

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

In our final DeviceTalks Weekly of the year, the news team assembles to highlight MassDevice’s Top Medtech Trends of 2023. Let us know if you think we missed something, but we think we recorded all the hits. Thank you for being part of DeviceTalks! We look forward to sharing YOUR stories in 2024. Happy New Year and Go Medtech!

Thank you for listening to the DeviceTalks Weekly Podcast.

Please subscribe to the DeviceTalks Podcast Network.

This episode of DeviceTalks AI explores the potential for data-driven innovation in healthcare, through conversations with leaders at Microsoft and 1910 Genetics.

In the first segment, Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences at Microsoft, discusses the significance of computation, an essential element of AI investments, in enhancing R&D productivity in healthcare. She emphasizes the need for new approaches to drug development, including shorter clinical trial timelines and the shift toward more efficient R&D. Bonfiglioli also highlights the importance of multimodal data in research and development. In addition, speaks to the integral role of computational methods in drug development, emphasizing how they augment our disease understanding and clinical trial design.

In the second segment, Jen Nwankwo, PhD, Founder & CEO of 1910 Genetics - a Y Combinator and Sam Altman-backed startup, shares the innovation strategies around drug discovery. She details their problem-first approach, leading to an integrated, modality-agnostic drug discovery tech stack. Dr. Nwankwo highlights the use of Azure Quantum Elements in accelerating molecular simulations, positioning 1910 Genetics uniquely in designing both small and large molecules. Their global approach to accessible drug discovery through strategic partnerships is emphasized.

Join us for the next episode of DeviceTalks AI, featuring an exclusive interview with Ben Newton, Chief Digital Officer and GM of Oncology at GE Healthcare.

Thank you to our contributors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support.

Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH, LISTEN, and READ. Thank you for supporting DeviceTalks AI!

Read Now: www.drugdiscoverytrends.com/microsoft-1910-genetics-data-hidden-gems

In this episode, we’ll talk with Medtech Industry Veteran Bill Hunter about the state of Medtech. The CEO of Canary Medical, a leader in medical device sensor technology and data collection, draws lessons from his long career in the industry, sharing his victories and a moment he had previously considered a defeat. Be sure to follow Bill Hunter on LinkedIn. Then, CEO Blake Richards introduces us to Elucid, which developed a software as a service company that can help physicians to better determine the severity of vascular disease. How did Elucid raise over $100 million and venture capital, and what new policies will bolster its bottom line.

Thanks for listening to the DeviceTalks Weekly Podcast.

Please subscribe to the DeviceTalks Podcast Network.

In the second episode of MedtechWOMEN Talks, our guest Kathryn Rieger, PhD, Sr. Director, Human Factors & User Research at Intuitive, shares her insights on the medical device product development cycle from the perspective of "The Engineer."

Drawing from her unique background in military tech and auto tech and her extensive experience in medtech, Dr. Rieger shares insights into how engineers influence the essential stages of the medical device product development cycle.

In the episode, Dr. Rieger emphasizes the rigorous nature of verification and validation processes in medtech, underlining the importance of document control and thorough testing to ensure device safety and functionality. She also highlights the role of clinical studies in pre-market validation, underlining the significance of balancing safety considerations with regulatory compliance. Additionally, Dr. Rieger discusses the growing role of AI and machine learning in optimizing development processes while prioritizing user needs and safety.

TL;DR - Key takeaways:

1. Integrating user experience and safety is crucial in medical device development.

2. A multidisciplinary approach to medtech product development is key.

3. Effective collaboration and communication are critical to successful product launches.

Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support.

aptyx.com

catalyzehealthcare.com

confluentmedical.com

cretex.com

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for supporting MedtechWOMEN Talks!

In this episode we’ll talk with Sean Gilligan, chief operating officer at AVS (Amplitude Vascular Systems), about that company’s big play in intravascular lithotripsy, the approached pioneered by vascular leader Shockwave Medical. Gilligan gives some detail on the company’s new approach and shares some insights from his own career as well. We also visit with Steve Levine, Sr. Director, Virtual Human Modeling, and Afrah Shafquat, Senior Data Scientist, both of Dassault Systemes, which sponsored this episode. The pair shared insights on what medical device companies can expect to see from a new set of guidelines being issued for digital simulations in Medtech regarding in silico clinical trials. For more information go to https://www.3ds.com/industries/life-sciences-healthcare/medical-device.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

In this episode of Boston Scientific Talks, Paudie O'Connor, SVP of Global Supply Chain, reflects on how Boston Scientific is overcoming initial supply chain challenges by establishing a new operational efficiency and sustainability standard.

Additionally, O'Connor highlights Boston Scientific's strategic shift towards more sustainable practices, including a significant reduction in carbon footprint by transitioning from air to ocean freight, reducing carbon footprint by 96%, and aiming for a 90% ocean freight rate by 2026. This shift necessitates infrastructural investments, such as building sterilization facilities closer to manufacturing sites, enabling direct market shipping, and transitioning from air to sea where feasible.

The discussion also covers innovations in packaging, with a move towards digital instructions and tailored packaging for different markets. This approach aligns with environmental goals while catering to diverse regulatory requirements. Lastly, O'Connor speaks to the role of supplier partnerships in achieving these ambitious targets, underlining Boston Scientific's commitment to not only navigating but also redefining the supply chain norms in the medical device industry.

Listen to this episode of the DeviceTalks Weekly Podcast to hear more about Paudie O'Connor's career and work at Boston Scientific. https://www.devicetalks.com/what-boston-scientifics-evolving-supply-chain-strategy-means-for-partners-productivity-and-ma/ 

Thank you to Xometry for sponsoring this episode. Visit www.xometry.com to learn more about Xometry and get an instant quote or injection molding quote today. 

Thank you for listening to the Boston Scientific Podcast.

Subscribe to this podcast on every major podcast platform.

In this episode of StrykerTalks, neurovascular president Jim Marucci discusses the company's latest advancements in neurovascular technology and how that, and its expanding global footprint, are shaping the future of its neurovascular division.

Marucci details the company's recent strategic acquisition of Cerus Endovascular, which has increased Stryker's capabilities in treating wide-neck bifurcated aneurysms. Furthering Stryker's goal to simplify procedures, reduce costs, and improve patient outcomes.

The conversation also touches on developing new products like the Target Tetra detachable coil for smaller aneurysms and the potential of emerging technologies like AI, AR, and VR in neurovascular procedures. Marucci anticipates these technologies will play a crucial role in advancing the field and improving access to care globally.

Tune in for a comprehensive overview of Stryker's current strategies, product innovations, and future directions in the neurovascular sector, underlining its commitment to enhancing stroke care and neurovascular treatments worldwide.

Thank you to Zeus for sponsoring this episode. To learn more about how Zeus works with medical device companies, visit www.zeusinc.com.

Thank you for listening to the StrykerTalks Podcast.

Subscribe to this podcast on every major podcast platform.

In the first episode of the newest series from the DeviceTalks Podcast Network, our guest Kirsten Carroll, CEO of Kandu Health shares her insights on the medical device product development cycle from the perspective of "The Product Director."

With more than a decade and a half in product management for Boston Scientific and Stryker Neurovascular, Kirsten discusses the roles of product management, design verification, and design validation in ensuring a successful product launch. She also highlights the significance of generating clinical evidence and tailoring it to different stakeholders. Kirsten's key message is the value of effective communication and collaboration in developing and launching medical devices.

TL;DR Key take-aways:

1. Collaboration between different teams is crucial in the medical device product development cycle.

2. User needs should be clearly defined and translated into specifications for design verification.

3. Design validation involves testing the product with the intended users to ensure it meets their expectations.

4. Clinical evidence generation should align with the specific needs of different stakeholders.

5. Effective communication and collaboration are essential for successful product development and launch.

Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent, and Cretex Medical for providing vital support.

aptyx.com

catalyzehealthcare.com

confluentmedical.com

cretex.com

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for supporting MedtechWOMEN Talks.

In this episode, we’ll hear from Fred Khosravi, CEO of Imperative Care, a medical device company that is taking an unusually holistic approach to helping people who have suffered strokes. Host Tom Salemi interviewed the successful medical device CEO at DeviceTalks West.

Before that we’ll talk with Delphine Zurkiya, senior partner at McKinsey & Co., about a new report that lays out a blueprint for medical device companies to improve efficiencies in R&D and customer outreach.

But first we’ll highlight our newest member of the DeviceTalks Podcast family – AI Meets Life Sci – with co-hosts Kayleen Brown and Brian Buntz!

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast application.